Logotype for HOYA Corporation

HOYA (7741) Q4 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for HOYA Corporation

Q4 2026 earnings summary

30 Apr, 2026

Executive summary

  • Consolidated revenue and operating profit reached historical highs in Q4 FY25, driven by strong demand in the Information Technology business and robust Life Care segment performance.

  • Full-year revenue rose 9.4% to ¥947.7 billion, with profit before tax up 26% to ¥327.7 billion and net profit attributable to owners up 25.2% to ¥253.1 billion.

  • Both Life Care and Information Technology segments contributed to growth, with advanced semiconductor products and health care/medical products performing strongly.

  • Cash and cash equivalents increased to ¥574.1 billion at year-end, and annual dividends per share rose to ¥295.

Financial highlights

  • Q4 FY25 revenue: ¥248.1bn, up 15% year-over-year (CC +9%); Q4 operating profit: ¥74.7bn, up 14% (CC +10%); Q4 pretax profit: ¥77.6bn, up 15%.

  • Q4 basic EPS: ¥160.80, up from ¥149.53 a year earlier.

  • Q4 operating cash flow: ¥79.7bn; free cash flow: ¥65.8bn.

  • Full-year FY25 revenue: ¥947.7bn, up 9% (CC +8%); operating profit: ¥285.2bn, up 12% (CC +11%); pretax profit: ¥327.7bn, up 26% (CC +26%).

  • Full-year operating cash flow: ¥278.4bn; free cash flow: ¥270.9bn.

Outlook and guidance

  • FY26 targets stable growth in eyeglass lenses via high-value-added products and expansion in progressive lenses.

  • Plans to expand sales of ATIOLS and stabilize supply in IOLS segment.

  • Focus on expanding high-value-added masks in FPD and non-digital camera segments in Imaging.

  • Continued investment in production capacity for EUV blanks and HDD substrates.

  • Management expects continued growth, supported by strong demand in both Life Care and Information Technology segments, but notes risks from currency fluctuations and global economic conditions.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more